This document provides guidelines for administration of stock epinephrine auto-injectors in schools in accordance with state statutes.

(a) The district board shall permit a student to possess and self-administer within any school of the district medication required for potentially life threatening conditions if a written statement is submitted to the district containing applicable:

• (i) Parental verification that the student is responsible for and capable of self-administration and parental authorization for self-administration of medication required for potentially life threatening conditions;
• (ii) Health care provider identification of the prescribed or authorized medication required for potentially life threatening conditions and verification of the appropriateness of the student's possession and self-administration of the medication required for potentially life threatening conditions. (b) The written statement shall be prescribed by the department of education, with the assistance of the department of health, and shall require the signatures of the parent or guardian of the student and the student's physician or physician's representative. (c) As used in this section:
• (i)“Asthma medication” means prescription or nonprescription inhaled asthma medication;
• (ii)“Potentially life threatening conditions” includes, but is not limited to asthma, food allergies and insect bites;
• (iii)“Medication required for potentially life threatening conditions” includes, but is not limited to asthma medication and prescription single dose epinephrine pens

(b) A district board that decides to acquire, maintain and dispense a supply of epinephrine auto-injectors shall:

• (i) Implement a plan based on the guidelines developed pursuant to this section for the management of students with life threatening allergies enrolled in the schools within the district;
• (ii) Make the plan available on the school district's website or the website of each school within the district, or if such websites do not exist, make the plan publicly available through other practicable means as determined by the board. (c) Not later than December 31, 2014, the department of education, in consultation with the department of health, shall develop and make available to all schools guidelines for the management of students with life threatening allergies. The guidelines shall include, but not be limited to:
• (i) Identification of life threatening allergies or severe allergic reactions qualifying for administration of epinephrine auto-injectors under this act;
• (ii) Identification of appropriate and acceptable epinephrine auto-injectors;
• (iii) Education and training for school personnel on the management of students with life threatening allergies, including training related to the administration of epinephrine auto-injectors;
• (iv) Procedures for responding to life threatening allergies;

(c)(v) A process for the development of individualized health care and allergy action plans for every student with a life threatening allergy;

• (vi) Protocols to prevent exposure to allergens;
• (vii) Requirements for each school to keep a record of each incident that involves a life threatening allergy or the administration of stock epinephrine auto-injectors;
• (viii) Requirements for schools that have adopted a policy allowing for the administration of stock epinephrine auto-injectors pursuant to this section to maintain a list of employees in the school or school district who have been trained and assigned to administer stock epinephrine auto-injectors;
• (ix) Requirements for school nurses and assigned school personnel to confirm completion of a training program approved by the department of education, in consultation with the department of health.